GPR176 and breast carcinoma: Here, we found that GPR176 was downregulated in breast cancer by both real-time PCR and bioinformatics analysis, but upregulated by both western blot and immunohistochemistry, indicating that aberrant GPR176 expression plays an important role in breast carcinogenesis.